NCT06576258View on ClinicalTrials.gov

The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 19, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Bloodstream Infection
Interventions
DIAGNOSTIC_TEST

cobas eplex multiplex PCR

Positive blood culture samples from the intervention group are subjected to cobas eplex multiplex PCR in addition to the SOC culture methods.

Trial Locations (1)

2650

RECRUITING

University Hospital Antwerp, Edegem

All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

University Hospital, Antwerp

OTHER